NCT00166452View on ClinicalTrials.gov

A Study of the Effect of Lenalidamide on Complex Regional Pain Syndrome Type 1

PHASE3CompletedINTERVENTIONAL

Enrollment

7

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

April 30, 2007

Study Completion Date

February 28, 2009

Conditions

Complex Regional Pain Syndrome, Type 1

Interventions

DRUG

Lenalidamide

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

Elgene Chemical

All Listed Sponsors

collaborator

Elgene Chemical

INDUSTRY

lead

Mayo Clinic

OTHER